Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer

NCT00195039 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu -J591)

Sponsor

Weill Medical College of Cornell University